Appendix A
Information Gathering Workshop Agenda
Committee on Examining the Probable Consequences of Alternative Patterns of Widespread Antiretroviral Drug Use in Resource-Constrained Settings
Tuesday, January 27, 2004
Room 100, Keck Building
500 5th Street, NW
Washington, DC 2001
8:00-8:20 |
Welcome, Introduction of Committee, and Statement of Charge |
Dr. James Curran and Dr. Haile Debas |
|
Committee Cochairs |
The Opportunity
8:20-8:45 |
The Challenge of HIV/AIDS in 2004 and the WHO 3 × 5 Program |
Dr. Jim Kim |
|
Advisor to the Director-General |
|
World Health Organization |
|
Geneva, Switzerland |
8:45-9:10 |
The Global Funds’ Lessons Learned Regarding ARV Drug Scale-up in Resource-Constrained Settings |
Dr. Bernhard Schwartlander |
|
Director |
|
Strategic Information and Measurement |
|
Global Fund to Fight AIDS, TB, and Malaria |
|
Geneva, Switzerland |
|
9:10-9:35 |
The U.S. Emergency Plan for Antiretroviral Scale-up: The Latest Programmatic Developments |
Dr. Joe O’Neil |
|
Deputy Coordinator |
|
Office of the Global AIDS Coordinator |
|
Department of State |
|
Washington, DC |
|
9:35-9:55 |
General Discussion |
9:55-10:15 |
BREAK |
Antecedents
10:15-10:40 |
Durability of ARV Therapy: U.S. Experience and Its Implications for Resource-Constrained Settings |
Dr. Robert Redfield |
|
Cofounder and Director of Clinical Care and Research Division, Institute of Human Virology |
|
University of Maryland |
|
Baltimore, MD |
|
10:40-11:05 |
A U.S. Clinical Perspective on the Implications of ARV Resistance for Resource-Constrained Settings |
Dr. Steven Deeks |
|
Associate Clinical Professor of Clinical Medicine |
|
University of California, San Francisco |
|
San Francisco, CA |
|
11:05-11:30 |
Lessons Learned from the Scale-up of ARV Treatment in Brazil |
Dr. Mauro Schechter |
|
Professor of Infectious Diseases |
|
Universidade Federal do Rio de Janeiro, Brazil |
11:30-11:55 |
Lessons Learned from the Use of ARVs in Very Low-Resource Settings: The Haiti Experience |
Dr. Daniel Fitzgerald |
|
Groupe Haitien d’Étude du Sarcome de Kaposi et des infections Opportunistes (GHESKIO) Port-au-Prince, Haiti, and |
|
Division of International Medicine and Infectious Diseases |
|
Cornell University Medical College |
|
New York, NY |
|
11:55-12:20 |
MSF Perspectives on ARV Administration: Experiences from 20 countries and 10,000 Patients |
Ms. Rachel Cohen |
|
U.S. Director, Campaign for Access to Essential Medicines |
|
Médecins sans Frontières |
|
New York, NY |
|
12:20-12:50 |
General Discussion |
12:50-1:50 |
LUNCH |
Clinical Principles for ARV Scale-up Programs
1:50-2:15 |
The 2003 WHO Guidelines for ARV Use: Perspectives from a User |
Dr. John Idoko |
|
Professor |
|
Jos University Teaching Hospital |
|
Jos, Nigeria |
|
2:15-2:40 |
MTCT-Plus Initiative: Perspectives from a Multicountry Comprehensive HIV Care and Treatment Program |
Dr. Wafaa El-Sadr |
|
Professor |
|
Mailman School of Public Health |
|
Columbia University and Harlem Hospital |
|
New York, NY |
2:40-3:05 |
The Role of the Laboratory in Managing ARV Care in a Country with Highly Limited Resources |
|
Dr. Brooks Jackson |
|
Baxley Professor and Director of Pathology |
|
Johns Hopkins University School of Medicine |
|
Baltimore, MD |
3:05-3:30 |
The Social and Behavioral Dimensions of Adherence: Implications for Patient Education |
|
Dr. Carla Makhlouf Obermeyer |
|
Scientist |
|
Department of HIV/AIDS |
|
World Health Organization |
|
Geneva, Switzerland |
3:30-3:50 |
General Discussion |
3:50-4:10 |
BREAK |
4:10-4:35 |
Preventing Mother-to-Child Transmission: Issues of Therapy and Resistance |
|
Dr. Lynne Mofenson |
|
Pediatric, Adolescent and Maternal AIDS Branch |
|
Center for Research for Mothers and Children |
|
National Institute of Child Health and Human Development |
|
National Institutes of Health |
|
Bethesda, MD |
4:35-5:00 |
Pediatric Considerations for ARV Programs in Resource-Constrained Settings |
|
Dr. Mark Kline |
|
Chief, Retrovirology Clinic |
|
Professor of Pediatrics |
|
Director, Baylor International Pediatric AIDS Initiative |
|
Baylor College of Medicine/Texas Children’s Hospital |
|
Houston, TX |
5:00-5:25 |
The Integration of Counseling, Prevention, and ARV Programs |
|
Dr. Sam Dooley |
|
Division of HIV/AIDS Prevention |
|
Centers for Disease Control and Prevention |
|
Atlanta, GA |
5:25-6:00 |
Wrap-up Comments and Discussion |
Wednesday, January 28, 2004
Management Principles for Scale-up of ARV Programs
8:00-8:05 |
Opening Comments |
|
Dr. James Curran and Dr. Haile Debas |
|
Committee Cochairs |
8:05-8:30 |
Principles of Design and Scale-up for National Clinical Care Programs and Applications to the WHO 3 × 5 Targets |
|
Dr. M. Rashad Massoud |
|
Vice President and Director |
|
Quality and Performance Institute |
|
University Research Co., LLC |
|
Bethesda, MD |
8:30-8:55 |
An Overview of Health Care Manpower, Health Care Infrastructure, and Economics in Select Resource-Poor Countries |
|
Mr. Mead Over |
|
Lead Economist |
|
Development Research Group |
|
World Bank |
|
Washington, DC |
8:55-9:20 |
The Role of Community Mobilization in the Scale-up of ARV programs |
|
Ms. Emi MacLean |
|
Médecins sans Frontières |
|
New York, NY |
9:20-9:45 |
Distribution of ARVs: Issues of Security, Logistics, and Quality |
|
Ms. Yasmin Chandani |
|
HIV/AIDS Advisor for DELIVER |
|
John Snow, Inc. |
|
Arlington, VA |
9:45-10:10 |
Large Scale Training for ARV Providers: Observations from the United States |
|
Dr. John McNeil |
|
Chief, Infectious Diseases |
|
Howard University |
|
PI, National Minority AIDS Education and Training Center |
|
Washington, DC |
10:10-10:30 |
General Discussion |
10:30-10:50 |
BREAK |
10:50-11:15 |
Perspectives on Purchasing First and Second Line ARVs |
|
Ms. Lynn Margherio |
|
Executive Vice President |
|
The Clinton Foundation HIV/AIDS Initiative |
11:15-11:40 |
Delivering ARVs: The Economic Consequences of Resistance |
|
Dr. Stefano Bertozzi |
|
Director |
|
Economics and Policy |
|
Center of Research on Health Systems |
|
National Institute of Public Health |
|
Cuernavaca, Mexico |
11:40-12:00 |
General Discussion |
12:00-1:00 |
LUNCH |
The Path Forward
1:00-1:25 |
Assessing Readiness for ARV Program Implementation |
|
Dr. Eric Goosby |
|
Chief Executive Officer |
|
Pangea Global AIDS Foundation |
|
San Francisco, CA |
1:25-1:50 |
Specific Questions for Operations Research in the Scale-up of ARV Treatment Programs in Low-Resource Settings |
|
Dr. Tom Quinn |
|
Professor of Medicine |
|
Johns Hopkins University School of Medicine |
|
Baltimore, MD |
1:50-2:15 |
The Role of Statistical Prediction Methods for Managing ARV Scale-up Programs |
|
Dr. Victor De Gruttola |
|
Professor of Biostatistics |
|
Harvard School of Public Health |
|
Boston, MA |
2:15-2:40 |
Ethical Issues in the Scale-up of ARV Programs in Resource-Poor Settings |
|
Ms. Angela Wasunna |
|
Lawyer/Bioethicist |
|
Associate for International Programs |
|
The Hastings Center |
|
Garrison, NY |
2:40-3:05 |
Discussion |
3:05-3:30 |
BREAK |
3:30-3:55 |
Information Management Considerations in Managing ARV Programs |
|
Mr. Ronaldo Lima |
|
International AIDS Vaccine Initiative |
|
New York, New York |
3:55-4:20 |
ARV Resistance: Epidemiologic Implications and Public Health Surveillance |
|
Dr. Diane Bennett |
|
World Health Organization |
|
Geneva, Switzerland |
4:20-4:45 |
Monitoring and Evaluation for ARV Programs in Resource-Poor Settings |
|
Dr. Paul DeLay |
|
UNAIDS |
|
Geneva, Switzerland |
4:45-5:10 |
The South African Plan for ARV Scale-up |
|
Dr. Tony Mbewu, |
|
Executive Director |
|
Medical Research Council of South Africa |
|
Capetown, South Africa |
5:10-6:00 |
Discussion and Wrap-up |